Polzik, Peter
Grøndal, Olav
Tavenier, Juliette
Madsen, Martin B.
Andersen, Ove
Hedetoft, Morten
Hyldegaard, Ole http://orcid.org/0000-0002-1147-379X
Funding for this research was provided by:
EC | Seventh Framework Programme (305340)
Rigshospitalet
Article History
Received: 6 September 2018
Accepted: 13 March 2019
First Online: 25 March 2019
Competing Interests
: Ove Andersen invented a patent concerning suPAR and risk stratification. Copenhagen University Hospital Hvidovre, Denmark, owns the patent, which is licensed to ViroGates A/S. ViroGates A/S produces the suPARnostic assay used for suPAR analysis in this study. All other authors report no competing interests.